I'm the declared fallback `codebuddy-cli/deepseek-v4-flash` continuing this bounded worker pass. Let me start by reading the initial read set.

I'm worker_02 on the fallback route. I need to find the frozen activity plan for package 80 and understand the project conventions. Let me explore the workspace structure.

Let me find the frozen activity plan (活动冻结计划) referenced by the task — the D001 II activity 131 package plan.

I need to locate the frozen activity plan (活动冻结计划) containing body.p1015-p1026 and package definitions. Let me search more broadly.

Let me look at the package 79 execution plan and worker_02 report as the template, plus the frozen plan structure for package 80.

The package 79 report gives me the exact template. Let me examine the research directory structure and the package 79 config/checklist/tests.

Now let me read the package 79 config, checklist, and test file as templates.

Now the package 79 checklist and test file.

Now let me examine the frozen plan for package 80 and the prepare harness.

Package 80 confirmed: 12 owned units `body.p1015-p1026`, id `pap-bb9bf95c9cd13f15e3b737f3`. Several units (p1015, p1017, p1020, p1021, p1025) look like structural headings. Let me read the prepare harness to understand config handling, especially `structural_only_source_refs`.

Now let me inspect the structure blob unit kinds and heading paths for p1015-p1026, plus verify the matrix/catalog files.

The blob is raw blocks. The structure units live in the coverage manifest. Let me inspect those.

All 12 units are `unit_kind: paragraph` in the manifest, with heading_paths. Let me check the frozen plan's own unit entries and how prior packages (75-79) handled structural headings in their configs.

Package 78 used structural_only for heading-only units. Let me check how package 78's config/tests handled structural refs, and read the reject gates module.

Let me check package 81's owned units (to define the later boundary) and the context units the frozen plan already assigns to package 80.

Let me look at package 77's config (AE/TEAE history boundary) to see which AE-definition refs were already closed.

The p78 config will show how structural-only owned refs are treated. Let me read it.

I now have the full pattern. Let me verify ownership and exact excerpts for all planned attached refs (p985-p994, p995-p1006, p1007-p1014, anchors p340/p835/p885/p315/p318).

All ownership verified. Let me pull the exact excerpts for attached refs I'll assert verbatim in tests.

I have everything needed. Creating the task list and then writing the three artifacts.

Checklist done. Now the deterministic test file.

Now run the dry-run prepare.

Prepare succeeded: owned=12, attached=35, unit=47, prompt 49402 chars. Now the test suite.

All four failures are assertion wording issues, not semantic defects. The flow note p340 uses "末次安全性随访" (not "最后一次"), the config's "混同" lives in `forbidden_inversion`, the note uses range "p1027-p1032", and the checklist uses spaced "第 81 包". Fixing the checklist text and test assertions.

Now fix the three test assertion defects.

The checklist uses "24 小时报告" (spaced). Normalizing to "24小时报告".

All 42 pass. Now adjacent regressions (packages 75-79 + shared suites).

Full directory: 252 passed. Verify prepare artifacts and prompt content.

All evidence in place. Compute config SHA and confirm created file set.

All work complete. Marking final task done.

# Execution Output: phase5-slice61br-package80-adr-susar-ae-collection-boundary - worker_02

## Boundary And Context Check

- **Fallback declaration**: I am the declared same-platform fallback `codebuddy-cli` / `deepseek-v4-flash` (primary `glm-5.3-flash` was unavailable before a resumable session existed). Delegated mode remained in effect; I preserved the bounded role, initial read set, task contract, quality gates, and conference-pass protocol. No capability limitation affected this work — config authoring, deterministic tests, and harness dry-run are all within this model's tools.
- **Initial read set**: read `context/phase5-slice61br-package80-adr-susar-ae-collection-boundary_execution_context.md` and `plans/codex_execution_phase5-slice61br-package80-adr-susar-ae-collection-boundary.md`. Work item 2 (worker_02) assigned and executed.
- **Hard boundaries honored**: worked only inside the runner CWD; no production paths read or written; no source protocol, official matrix, or shared harness file modified; no model/Agent invoked (dry-run prepare only); no subject/OCR/case review; `claims_complete=false` maintained. Did not create the runner-managed report file and no sibling process files.
- **Additional evidence read (within workspace)**: frozen plan `frozen_phase_plan.json`, coverage manifest, structure blob (`3946ea2c…`), official flow-controls matrix, procedure catalog, and the package 75-79 configs/checklists/tests as the template basis. All recorded as evidence, none as instructions.
- **Inference vs evidence**: package-80 ownership (12 units `body.p1015-p1026`, id `pap-bb9bf95c9cd13f15e3b737f3`) is direct frozen-plan evidence; the attached closure composition (35 refs) is my minimal-closure design choice based on textual dependency, following the established package 75-79 pattern — Codex retains authority over closure sufficiency.

## Work Performed

Based on the frozen 131-package plan (plan `papl-40b1237a22e538a278b4fd5e`, package 80 `pap-bb9bf95c9cd13f15e3b737f3`, owned units `body.p1015-p1026`, 12 units) I created the minimal model-free real-source closure for package 80 and its deterministic guard:

1. **Config** `configs/representative_group_package80_adr_susar_ae_collection_boundary.v1.json`:
   - `owned_source_refs` = `body.p1015-p1026` (12): ADR title/definition (p1015-p1016), SUSAR title/definition (p1017-p1018), unexpectedness definition (p1019), AE collection/recording headings (p1020-p1021), collection window (p1022), pre-first-dose history routing (p1023), eCRF recording (p1024), recording rules heading (p1025), single-event-term recording (p1026).
   - `structural_only_source_refs` (5 heading-only units): p1015, p1017, p1020, p1021, p1025 — chapter titles only, no independent control point; the 7 semantic units (p1016/p1018/p1019/p1022/p1023/p1024/p1026) keep `post_treatment_execution` disposition.
   - `attached_source_refs` (35, all read-only): package 77 AE/TEAE block `p985-p994` (AE definition "不一定与试验用药品有因果关系", AE record exclusions incl. p988 知情同意前已存在→病史/伴随疾病, TEAE "给药后"); package 78 SAE block `p995-p1006`; package 79 SAE tail `p1007-p1014` (p1014 医学和科学判断); flow anchors `p340` (D1给药后开始记录直至末次安全性随访)/`p835`/`p885`; ICF anchor `p315` (开始任何试验流程之前签署知情同意书); history-collection anchor `p318` (既往和现病史收集).
   - `required_candidate_source_refs=[]`; all 12 owned refs forbidden from emitting candidates (11 forbidden-upgrade markers each); `exception_semantics_by_source_ref` locks: ADR causality threshold (至少有一个合理的可能性/不能排除相关性, 不得改严或放宽), SUSAR 三维 AND (可疑+非预期+严重 同时满足), unexpectedness authority (《研究者手册》主要文件 + 性质/严重程度/后果/频率), collection window (首次服药后→最后一次安全性随访或退出研究, 以先发生时间为准), pre-dose routing (病史/伴随疾病 in 原始病历, 不作为AE), recording upper bound (末次访视 ≠ 最后一次安全性随访), single-event-term (单一事件项只记录一个术语).
   - `later_package_boundary`: `expected_owners_by_span` p1027-p1032 → package 81 (AE 记录规则), **not attached and not owned** (minimal closure — no textual dependency); note documents non-absorption of package 81, 85-86 特殊肝功能SAE, 90 因果共同判断, 92-99 报告时限与流程 (24小时报告).
2. **Parent clinical checklist** `slice61br-package80-adr-susar-ae-collection-boundary-parent-checklist.md`: boundary, rationale (7 risk items), per-source responsibility table (12 owned + 35 attached), 16-item blind parent checklist, success/stop conditions, immutable fingerprints.
3. **Deterministic tests** `test_slice61br_package80_adr_susar_ae_collection_boundary.py` (42 tests), locking:
   - config contract; owned == frozen package 80; structural titles separate from semantic units; attached == 35 read-only with documented ownership (p985-p994→77, p995-p1006→78, p1007-p1014→79, p835→75, p315/p318/p340/p885 unowned context).
   - verbatim owned excerpts (all 12); resolution role/excerpt checks; prepare evidence (12 owned + 35 attached in prompt); hydrated zero-candidate gate with counterexamples (CONTROL_DUPLICATE_RETAINED / DISPOSITION_MISMATCH).
   - ADR causality threshold gate: 改严/放宽/混同 counterexamples all rejected; causality dimension absent from SAE seriousness texts (p996/p997 carry no 因果关系) and ADR carries no seriousness.
   - SUSAR three-dimension AND gate: weakened counterexamples (丢失可疑/非预期/严重) rejected; 严重 dimension anchored to SAE standard (p996/p997/p1014).
   - Unexpectedness authority gate: reference-free counterexamples (no 《研究者手册》/主要文件/four attributes) rejected; p1018+p1019 reference cross-check; unexpectedness ≠ seriousness.
   - Pre-dose history routing: 给药前事件记为AE counterexamples rejected; ICF chain p315→p988→p1023→p318 consistent.
   - Collection window: 起点/终点漂移 counterexamples rejected; p1022↔p340 cross-check (last safety follow-up wording 最后一次 vs 末次); 末次安全随访 ≠ 末次访视 (p1022 vs p1024) with conflation counterexamples; "所有AE" full recording preserved.
   - Single-event-term gate: 拆分/合并 counterexamples rejected.
   - Forbidden-upgrade gate with per-ref screening/baseline counterexamples and no false positives on legitimate source text.
   - Official matrix: zero rows anchored in p985-p1032, zero 不良事件/TEAE/SAE rows; procedure catalog no AE node and no definition-span sources; known targets empty; workflow stages keep D1 pre-dose distinct; immutable fingerprints; checklist freeze.
4. **Prepare evidence** (generated by harness `--dry-run`, not hand-written): `slice59n-prepare/d001-ii-package80-adr-susar-ae-collection-boundary/` with `source_rows.json`, `replay-summary.json`, `freeze_provenance.json`, `clinical-qc.json`, `execution/{batch.json, prompt-meta.json, prompt.txt}` (49,402 chars prompt; verified to contain all key semantics).

## Artifacts And Evidence

| Artifact | Path (under `research/d001-ii-phase-closure/`) | Status |
|---|---|---|
| Config | `configs/representative_group_package80_adr_susar_ae_collection_boundary.v1.json` | created, config SHA-256 `c3b42b727ed7ea25c15620a77abda866be1ec96e9744d5e6d74b39f295497ffb` |
| Checklist | `slice61br-package80-adr-susar-ae-collection-boundary-parent-checklist.md` | created |
| Tests | `test_slice61br_package80_adr_susar_ae_collection_boundary.py` | created, 42 passed |
| Prepare evidence | `slice59n-prepare/d001-ii-package80-adr-susar-ae-collection-boundary/` (7 files) | generated by harness `--dry-run` |

Key evidence numbers: prepare `owned=12`, `attached=35`, `unit=47`, `prompt=49402` chars, `prompt_sha256=eb27e3e8…`, `claims_complete=false`; lookup counts `frozen_plan_owned=43`, `frozen_plan_context=4`; control batch `pcb-c4b0f6ba…`; official matrix zero rows anchored in p985-p1032; package 81 owns p1027-p1032 (6) per frozen plan.

## Commands And Observations

- `slice59n_representative_group_control_replay.py --config configs/representative_group_package80_adr_susar_ae_collection_boundary.v1.json --dry-run` (venv python 3.12) → succeeded first run; summary printed with expected counts (12/35/47).
- `pytest test_slice61br_package80_adr_susar_ae_collection_boundary.py -q` → **42 passed, 5 warnings** (first run 4 failures, all assertion-wording defects in my tests, not config/checklist semantics: (1) later-note uses range "p1027-p1032" not literal "body.p1032"; (2) p340 flow note uses "末次安全性随访" while p1022 uses "最后一次安全性随访"; (3) "混同" lives in `forbidden_inversion` not `exception_rule`; (4) checklist used spaced "第 81 包"/"24 小时报告" — normalized the checklist text).
- Adjacent regressions (`test_slice61bm/bn/bo/bp/bq_*`, `test_slice59n_representative_group_regressions.py`, `test_matrix_source_closure.py`, `test_slice61bk_efficacy_source_closure.py`) → **206 passed, 5 warnings**.
- Full phase-closure directory (`test_*.py`) → **252 passed, 5 warnings**.
- Observation: `.trellis/` is untracked in this worktree (same as package 79's run); all created artifacts are inside `.trellis/tasks/08-22-phase5-clinical-facts-profile/research/d001-ii-phase-closure/`, matching the established pattern.

## Blockers Or Missing Environment

- None. The project venv (`.venv/bin/python`, 3.12.13) was required and present; all runs used it explicitly.
- Remaining unverified by design (Codex authority): no clinical semantic replay was run, no subject/case review, no Patient Journey classification, no browser/visual checks — per the slice contract (`claims_complete=false`).

## Rerun Requests Or Next Step

- **Codex acceptance gate**: verify artifacts, tests, source claims, and that the dry-run prepare prompt contains the full 47-unit closure before any real semantic replay of package 80. If replay is approved, the next semantic pass must emit zero candidates from `body.p1015-p1026`; any candidate emission triggers `CONTROL_DUPLICATE_RETAINED`/marker gates before publication.
- **No rerun needed for this work item.** Natural successor work items (outside this worker's scope): worker_01's read-only cross-package semantics confirmation (body.p1015-p1026 vs package 79 SAE tail, packages 81-84 AE record rules, 85-86 liver injury, 90 causality, 92-99 reporting) and worker_03's independent counterexample review (causality/seriousness conflation, SUSAR AND weakening, expectedness without reference, pre-dose history as AE, missed post-dose AE, window conflation, single-event split/merge, premature absorption of liver-injury/causality/24-hour reporting). Package 81 (`body.p1027-p1032`) ownership remains for its own future slice; this slice must not be reported as package-80 semantic acceptance.
